These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10432945)
21. Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas. Lim SH; Marcus RE Blood Rev; 1992 Sep; 6(3):157-62. PubMed ID: 1422284 [TBL] [Abstract][Full Text] [Related]
22. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study. Eisenbeis CF; Grainger A; Fischer B; Baiocchi RA; Carrodeguas L; Roychowdhury S; Chen L; Banks AL; Davis T; Young D; Kelbick N; Stephens J; Byrd JC; Grever MR; Caligiuri MA; Porcu P Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6101-10. PubMed ID: 15447996 [TBL] [Abstract][Full Text] [Related]
23. Inroads in the therapy of indolent lymphomas: exploiting biological insights. McLaughlin P Cancer Invest; 1999; 17(1):73-86. PubMed ID: 10999051 [No Abstract] [Full Text] [Related]
24. Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma. McCune SL; Gockerman JP; Rizzieri DA JAMA; 2001 Sep; 286(10):1149-52. PubMed ID: 11559240 [No Abstract] [Full Text] [Related]
25. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Du X; Nagata S; Ise T; Stetler-Stevenson M; Pastan I Blood; 2008 Jan; 111(1):338-43. PubMed ID: 17895404 [TBL] [Abstract][Full Text] [Related]
26. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. Miller RA; Maloney DG; Warnke R; Levy R N Engl J Med; 1982 Mar; 306(9):517-22. PubMed ID: 6173751 [No Abstract] [Full Text] [Related]
28. Radioimmunotherapy of lymphoma: a UC Davis experience. Lewis JP; Denardo GL; Denardo SJ Hybridoma; 1995 Apr; 14(2):115-20. PubMed ID: 7590765 [TBL] [Abstract][Full Text] [Related]
29. Radioimmunotherapy of hematological cancer: problems and progress. Jurcic JG; Scheinberg DA Clin Cancer Res; 1995 Dec; 1(12):1439-46. PubMed ID: 9815942 [No Abstract] [Full Text] [Related]
30. The potential for immunoconjugates in lymphoma therapy. Liu SY; Press OW Hematol Oncol Clin North Am; 1997 Oct; 11(5):987-1006. PubMed ID: 9336727 [TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies. Targeted treatment. Mayo Clin Health Lett; 2003 Mar; 21(3):1-3. PubMed ID: 12703461 [No Abstract] [Full Text] [Related]
32. [Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas]. Sack A; Meusers P Strahlenther Onkol; 1999 Apr; 175(4):192-3. PubMed ID: 10230466 [No Abstract] [Full Text] [Related]
33. Bispecific antibodies in lymphoma. Brissinck J; Demanet C; Moser M; Leo O; Thielemans K Int Rev Immunol; 1993; 10(2-3):187-94. PubMed ID: 8360585 [No Abstract] [Full Text] [Related]
34. [Antibodies as specific tumor therapy agents. Wishful thinking or reality?]. Gramatzki M; Valerius T Internist (Berl); 1997 Nov; 38(11):1055-62. PubMed ID: 9453954 [No Abstract] [Full Text] [Related]
35. New targets for antibody therapy of pediatric B cell lymphomas. van Vuren A; Meyer-Wentrup F Pediatr Blood Cancer; 2014 Dec; 61(12):2158-63. PubMed ID: 25154500 [TBL] [Abstract][Full Text] [Related]
36. Prospects for immunotoxin therapy of non-Hodgkin's lymphoma. Grossbard ML; Fidias P Clin Immunol Immunopathol; 1995 Aug; 76(2):107-14. PubMed ID: 7614729 [TBL] [Abstract][Full Text] [Related]
40. [Bio-therapy in hematology: New treatment of non-hodgkin's lymphomas with monoclonal antibodies]. Rupniewska ZM; Legieć W Pol Arch Med Wewn; 1994 Aug; 92(2):193-5. PubMed ID: 7800589 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]